Mumtaz Jabeen
Overview
Explore the profile of Mumtaz Jabeen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan A, Alanazi A, Jabeen M, Chauhan A, Ansari M
Sci Rep
. 2022 Dec;
12(1):21350.
PMID: 36494417
No abstract available.
2.
Khan A, Alanazi A, Jabeen M, Chauhan A, Ansari M
Sci Rep
. 2019 Nov;
9(1):15825.
PMID: 31676815
Short interfering RNA (siRNA) possesses special ability of silencing specific gene. To increase siRNA stability, transportation and its uptake by tumor cells, effective delivery to the appropriate target cells is...
3.
Alanazi A, Khan A, Rehman M, Jabeen M, Algrain N, Baig M
J Biomol Struct Dyn
. 2019 Jun;
38(8):2389-2401.
PMID: 31226916
In the present study, we have analyzed the biophysical interactions of alpha-linolenic acid conjugate (2,6P-ALA) with human serum albumin (HSA) and calf thymus DNA (CT-DNA); and also determined its effect...
4.
Khan A, Alanazi A, Jabeen M, Khan S, Malik A
Eur J Pharm Sci
. 2018 Apr;
119:171-178.
PMID: 29653177
Cryptococcus neoformans is one of the most lethal fungi causing mortality across the globe. Immuno-competent patients and patients taking immuno-suppressive medications are extremely susceptible to its infection. For effective removal...
5.
Khan A, Jabeen M, Alanazi A, Khan A
Braz J Infect Dis
. 2016 Jun;
20(4):342-8.
PMID: 27294976
A natural and biocompatible fibrin microsphere is one of the most promising dual delivery vehicle as compared to other traditionally designed delivery modalities. It represents sustained delivery of encapsulated drug...
6.
Khan A, Alanazi A, Jabeen M, Hassan I, Bhat M
Biomed Pharmacother
. 2016 Jun;
81:394-401.
PMID: 27261618
The present approach enumerates the effectiveness of tuftsin tagged nano-liposome for the cytosolic transport of 2,6-di-isopropylphenol-linolenic acid conjugate against liver cancer in mice. Initially, the conjugate in its free form...
7.
Khan A, Alanazi A, Jabeen M, Parvez M, Wahab R, Abdelhameed A, et al.
J Fluoresc
. 2015 Mar;
25(3):527.
PMID: 25808595
No abstract available.
8.
Khan A, Alanazi A, Jabeen M, Parvez M, Pervez K, Wahab R, et al.
J Fluoresc
. 2015 Feb;
25(3):519-25.
PMID: 25638605
Novel conjugate 2,6-Diisopropylphenol-Oleic acid (2,6P-OLA) has shown potent anticancer activity on various cancer cell lines (Khan et al. Lipids 47:973-986, 2012). In the present study, the protein-or/ and DNA-binding property...
9.
Khan A, Alanazi A, Jabeen M, Chauhan A, Abdelhameed A
Anticancer Res
. 2013 Jun;
33(6):2517-24.
PMID: 23749903
Aim: Chemical synthesis and characterization of a lipophilic ester conjugate, propofol stearate and evaluation of its anticancer efficacy on human breast cancer cell lines MDA-MB-361, MCF-7 and MDA-MB-231. Materials And...
10.
Khan A, Jabeen M, Khan A, Owais M
Nanomedicine (Lond)
. 2013 Jan;
8(8):1281-94.
PMID: 23311988
Aim: The preparation and characterization of a novel escheriosomal nanoparticle formulation of a potent anticancer conjugate, 2,6-diisopropylphenol-linoleic acid (2,6P-LA), and evaluation of its anticancer efficacy against diethyl nitrosamine-induced hepatocellular carcinoma...